Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.71%
EBIT Growth (5y)
7.11%
EBIT to Interest (avg)
-57.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.28
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.90
EV to EBIT
-1.89
EV to EBITDA
-2.11
EV to Capital Employed
-16.49
EV to Sales
182.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-827.60%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Bearish
Bearish
OBV
No Trend
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -86.89 MM
NET PROFIT(HY)
Higher at SEK -70.8 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1,049.79 times
-23What is not working for the Company
NET PROFIT(9M)
At SEK -128.59 MM has Grown at -61.52%
NET SALES(HY)
At SEK 0.19 MM has Grown at -40.31%
INTEREST(HY)
At SEK 25.72 MM has Grown at 1,416.27%
ROCE(HY)
Lowest at -827.51%
RAW MATERIAL COST(Y)
Grown by 105.42% (YoY
CASH AND EQV(HY)
Lowest at SEK 55.84 MM
DEBT-EQUITY RATIO
(HY)
Highest at 75.11 %
Here's what is working for Immunovia AB
Operating Cash Flow
Highest at SEK -86.89 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Net Profit
Higher at SEK -70.8 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
Inventory Turnover Ratio
Highest at 1,049.79 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Immunovia AB
Net Sales
At SEK 0.19 MM has Grown at -40.31%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (SEK MM)
Interest
At SEK 25.72 MM has Grown at 1,416.27%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Cash and Eqv
Lowest at SEK 55.84 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 75.11 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 105.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
